SCHEMBL18962972

SCHEMBL18962972

C[C@](CO)(C[C@@H](Cc1ccc(-c2cc(Cl)ccc2F)cc1)NC(=O)C(N)=O)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 19/20 0.67
▸ ACE P12821 4/20 0.67
▸ MMEL1 Q495T6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17980263 1.00 MME (0.67) MMEACEMMEL1
SCHEMBL17968665 1.00 MME (0.67) MMEACEMMEL1
SCHEMBL14890607 0.92 MME (0.79) MMEACEMMEL1
SCHEMBL22331066 0.92 MME (0.79) MMEACEMMEL1
SCHEMBL16241271 0.92 MME (0.79) MMEACEMMEL1
SCHEMBL19705947 0.92 MME (0.79) MMEACEMMEL1
SCHEMBL17968666 0.88 MME (0.52) MMEACEMMEL1
SCHEMBL17968663 0.87 MME (0.64) MMEACEMMEL1
SCHEMBL17980206 0.87 MME (0.64) MMEACEMMEL1
SCHEMBL19705880 0.87 MME (0.64) MMEACEMMEL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682052-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2017-06-20 — — US disclosed
Send feedback